Over 140,000 bottles of cholesterol medication recalled. See affected products.

The FDA said that over 140,000 bottles of the Lipitor generic potentially failed to meet "dissolution specifications." ...
Health on MSN

FDA Announces Nationwide Recall of Cholesterol Medication—More Than 140,000 Bottles Affected

The FDA announced a nationwide recall of Atorvastatin Calcium tablets, a statin used to lower cholesterol, due to potential ...
Medscape

FDA OKs Rybelsus to Reduce CV Risk in T2D

Novo Nordisk’s oral semaglutide Rybelsus reduced the risk for major adverse cardiovascular events by 14% in people with type ...
MedPage Today on MSN

FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection

Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...
New Atlas

First oral GLP-1 cuts cardiovascular risk by 14% – and it's now FDA-approved

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...
The American Journal of Managed Care

FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

The FDA has expanded the label for oral semaglutide (Rybelsus; Novo Nordisk) tablets 7 mg and 14 mg to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who ...
Indiatimes

BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times ...

antibiotic, (iii) Ulcimax tablets (20 & 40 mg.), a long-acting H2 antogonist for peptic ulcers and (iv) theoped syrup, a paediatric bronchodilator. Sales in the Company's `PROTEC' division exceeded Rs ...